Green Cross Q2 Profit Misses Estimates on GC Wellbeing Exit, Flu Vaccine Delays
Green Cross reported Q2 consolidated revenue of 421.2 billion won and operating profit of 1.7 billion won, missing analyst expectations as the company deconsolidated GC Wellbeing and delayed recognition of high-margin seasonal products to the second half. The results represented year-over-year
GC Holdings-0.59%
GC Cell0.74%
LucasBennett·07-31 07:17
